Peter Feldman on Muck Rack

Peter Feldman

Verified
Johannesburg
As seen in: LinkedIn, Wiley Online Library, IOL Entertainment, EClinicalMedicine, The Citizen (South Africa), Mondaq, Youth Today, Daily Voice (South Africa), Journal of Clinical Epidemiology, Jewish Report -(South Africa)
Journalist and arts writer for 50 years who loves movies, theatre, music and good food.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Peter

Contact Peter, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Shifting the culture of youth sport by supporting coaches

|
By Dawn Anderson-Butcher, Meghan Bartlett, Peter Feldman Verified, Katlin Okamoto
| Youth Today Verified
Across the country, a growing number of organizations are working to fundamentally shift the culture of youth sports by transforming how we prepare and support the people at its heart: coaches. These leaders recognize that if sport is to fulfill its promise as a space for positive youth development, then coaching must be about far more than drills and playbooks. It must be about relationships, healing, community and purpose.
Open in Who Shared Issue with article?

“We are not invited”: Australian focus group results on how to improve ethnic diversity in trials.

|
By Bianca Brijnath, Rachel Muoio, Peter Feldman Verified, Vivian Welch
| Journal of Clinical Epidemiology Verified
This paper is only available as a PDF. To read, Please Download here. Highlights What is new? Key findings • 16 focus groups from 21 different ethnic communities indicated strong support for taking part in medical research, including trials.
Open in Who Shared Issue with article?

Preclinical development and characterization of a human plasma‐derived high‐purity factor X concentrate for therapeutic use

|
By Joanne Lloyd, Peter Feldman Verified
| Wiley Online Library Verified
1 INTRODUCTION Human coagulation factor X deficiency is a very rare autosomal recessive condition affecting between 1 in 500,000 and 1 in 2 million people. The deficiency is caused by F10 gene mutations on chromosome 13. The condition is characterised by spontaneous bleeding, which can be life-threatening.1, 2 Historically, such bleeds have been treated with fresh-frozen plasma or prothrombin complex concentrates (PCC).
Open in Who Shared Issue with article?
See all 196 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified